Targeting Endothelial Connexin37 Reduces Angiogenesis and Decreases Tumor Growth
Authors:
- Karthik SathiyanadanKSKarthik Sathiyanadan
- Florian AlonsoFAFlorian Alonso
- Sonia Domingos-PereiraSDSonia Domingos-Pereira
- Tania SantoroTSTania Santoro
- Lauriane HamardLHLauriane Hamard
- Valérie CessonVCValérie Cesson
- Paolo MedaPMPaolo Meda
- Denise Nardelli-HaefligerDNDenise Nardelli-Haefliger
- Jacques-Antoine HaefligerJHJacques-Antoine Haefliger
Open Access
- 8 March 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (6) , 2930
Abstract
Connexin37 (Cx37) and Cx40 form intercellular channels between endothelial cells (EC), which contribute to the regulation of the functions of vessels. We previously documented the participation of both Cx in developmental angiogenesis and have further shown that loss of Cx40 decreases the growth of different tumors. Here, we report that loss of Cx37 reduces (1) the in vitro proliferation of primary human EC; (2) the vascularization of subcutaneously implanted matrigel plugs in Cx37−/− mice or in WT using matrigel plugs supplemented with a peptide targeting Cx37 channels; (3) tumor angiogenesis; and (4) the growth of TC-1 and B16 tumors, resulting in a longer mice survival. We further document that Cx37 and Cx40 function in a collaborative manner to promote tumor growth, inasmuch as the injection of a peptide targeting Cx40 into Cx37−/− mice decreased the growth of TC-1 tumors to a larger extent than after loss of Cx37. This loss did not alter vessel perfusion, mural cells coverage and tumor hypoxia compared to tumors grown in WT mice. The data show that Cx37 is relevant for the control of EC proliferation and growth in different tumor models, suggesting that it may be a target, alone or in combination with Cx40, in the development of anti-tumoral treatments.Keywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31003A-175452/1)
- Swiss Cancer League (KFS-3796-02-2016)
This publication has 68 references indexed in Scilit:
- Defective Cx40 Maintains Cx37 Expression but Intact Cx40 Is Crucial for Conducted Dilations Irrespective of HypertensionHypertension, 2012
- Normalization of the Vasculature for Treatment of Cancer and Other DiseasesPhysiological Reviews, 2011
- Connexin Channels Provide a Target to Manipulate Brain Endothelial Calcium Dynamics and Blood—Brain Barrier PermeabilityJournal of Cerebral Blood Flow & Metabolism, 2011
- The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting AgentsCancer Treatment Reviews, 2011
- An angiotensin II- and NF-κB-dependent mechanism increases connexin 43 in murine arteries targeted by renin-dependent hypertensionCardiovascular Research, 2010
- Connexin 43 mediates endothelium-derived hyperpolarizing factor-induced vasodilatation in subcutaneous resistance arteries from healthy pregnant womenAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Effects of connexin‐mimetic peptides on gap junction functionality and connexin expression in cultured vascular cellsBritish Journal of Pharmacology, 2005
- Junctional and nonjunctional effects of heptanol and glycyrrhetinic acid derivates in rat mesenteric small arteriesBritish Journal of Pharmacology, 2004
- Endothelium‐dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis?British Journal of Pharmacology, 2004
- A role for heterologous gap junctions between melanoma and endothelial cells in metastasisJournal of Clinical Investigation, 2000